
Antonio Borregon
Head Global Business Development Pharma
QbD Group
About me
Dr. Borregón is a seasoned professional with over two decades of international experience in senior management roles, notably as the former A. Vice President of Global Marketing at Merck & Co. His expertise spans various facets of the pharmaceutical and healthcare industries, including the design and implementation of Business Development Strategies, Market Access models for drugs, biologicals, biosimilars, vaccines, and medical technology.
As an advocate for transformation in the LIFE Sciences sector, Dr. Borregón excels in bridging research with jgap between health professionals, patients, consumers, and managers in both public and private health systems.v His commitment to aligning the objectives of each participant has earned him recognition as a leading figure in the field.
A sought-after lecturer on innovation and recently , Dr. Borregón shares his wealth of knowledge at esteemed business schools. In 2020, he founded Health Digital First, a firm dedicated to driving digital innovation in healthcare. Ventured into consulting, he serves as Global Business Development at QbD Group HQ, where he advises companies on themes of strategic and operational nature, fostering the intersection of Health Sciences and Business Growth.
With a passion for leveraging innovation to catalyze sustainable growth, Dr. Borregón continues to support Life Sciences companies and public and private entities for positive change in the industry, empowering organizations to thrive in the new age.
Social media
Contact details
Is member of

QbD Group
Exhibitorsis attending
Harnessing AI in Clinical Practice to Drug Development and R&D. From the Bedside to Benches
Tuesday, October 28, 2025 2:45 PM to 3:10 PM
Hall 6.1 - 6.1C92
Gustavo Ferrer · Dr.Ferrer BioPharma and Moxie Health Group
Keynote: The Future of Packaging: How Smart and Connected Technologies Are Enhancing Consumer Interaction
Tuesday, October 28, 2025 10:00 AM to 10:30 AM
Hall 8 - 8.0J60
Clinical Innovation in Obesity: The Next Five Years in Obesity Development
Wednesday, October 29, 2025 12:15 PM to 12:40 PM
Hall 6.1 - 6.1C92
Aurelio Arias · IQVIA